Documentation Centre

 

 

  of 106 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Metabolism and metabolic disorders and the microbiome: The intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology. 2021;160:573-599 June 07, 2021 Metabolism and metabolic disorders and the microbiome: The intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology. 2021;160:573-599 Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K Key Publications
Impact of human visceral and glutealfemoral adipose tissue transplant on glycemic control in a mouse model of diet-induced obesity. Am J Physiol Endocrinol Metab. 2020;319:E519-E528. January 15, 2021 Impact of human visceral and glutealfemoral adipose tissue transplant on glycemic control in a mouse model of diet-induced obesity. Am J Physiol Endocrinol Metab. 2020;319:E519-E528. Tsiloulis T, Raajendiran A, Keenan SN, Ooi G, Taylor RA, Burton P, Watt MJ Key Publications
Dietary sugars alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins. Cell Metab. 2019;30:735-75 April 07, 2020 Dietary sugars alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins. Cell Metab. 2019;30:735-75 Softic S, Meyer JG, Wang GX, Gupta MK, Batista TM, Lauritzen HPMM, Fujisaka S, Serra D, Herrero L, Willoughby J, Fitzgerald K, Ilkayeva O, Newgard CB, Gibson BW, Schilling B, Cohen DE, Kahn CR Key Publications
Sugar-sweetened beverages decrease fat oxidation. Nat Rev Endocrinol. 2019;15:685 April 06, 2020 Sugar-sweetened beverages decrease fat oxidation. Nat Rev Endocrinol. 2019;15:685 Starling S Key Publications
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science. 2019;365:386-39 April 03, 2020 Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science. 2019;365:386-39 Chaurasia B, Tippetts TS, Mayoral Monibas R, Liu J, Li Y, Wang L, Wilkerson JL, Sweeney CR, Pereira RF, Sumida DH, Maschek JA et al. Key Publications
Nonalcoholic fatty liver disease, insulin resistance, and ceramides. N Engl J Med. 2019;381:1866-1869 April 03, 2020 Nonalcoholic fatty liver disease, insulin resistance, and ceramides. N Engl J Med. 2019;381:1866-1869 Samuel VT, Shulman GI Key Publications
Cellular origins of beige fat cells revisited. Diabetes. 2019 Oct;68(10):1874-1885. March 03, 2020 Cellular origins of beige fat cells revisited. Diabetes. 2019 Oct;68(10):1874-1885. Shao M, Wang QA, Song A, Vishvanath L, Busbuso NC, Scherer PE, Gupta RK Key Publications
Thioesterase superfamily member 2 promotes hepatic VLDL secretion by channeling fatty acids into triglyceride biosynthesis. Hepatology. 2019;70:496-510. January 20, 2020 Thioesterase superfamily member 2 promotes hepatic VLDL secretion by channeling fatty acids into triglyceride biosynthesis. Hepatology. 2019;70:496-510. Alves-Bezerra M, Li Y, Acuña M, Ivanova AA, Corey KE, Ortlund EA, Cohen DE Key Publications
Selective trafficking of fatty acids in the liver: Add them2 to the list of influencers. Hepatology. 2019;70:462-464. January 17, 2020 Selective trafficking of fatty acids in the liver: Add them2 to the list of influencers. Hepatology. 2019;70:462-464. Ginsberg HN Key Publications
PCSK9 in diabetes: sweet, bitter or sour? Eur Heart J. 2019;40:369-371 April 19, 2019 PCSK9 in diabetes: sweet, bitter or sour? Eur Heart J. 2019;40:369-371 Paneni F, Costantino S Key Publications

  of 106 Next page

Go to page: of